Apellis Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Wellington Management Group LLP(12.81%),Wellington Group Holdings LLP(12.81%)等
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Francois Cedric
Apellis Pharmaceuticals | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(5.1%)
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Watson David O.
Apellis Pharmaceuticals | 4:持股變動聲明-董事 Dunlop A. Sinclair
Apellis Pharmaceuticals | 4:持股變動聲明-董事 Dunlop A. Sinclair
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Chopas James George
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Chopas James George
Apellis Pharmaceuticals | 4:持股變動聲明-高管 DeLong Mark Jeffrey
Apellis Pharmaceuticals | 4:持股變動聲明-董事 Dunlop A. Sinclair
Apellis Pharmaceuticals | 4:持股變動聲明-董事 Dunlop A. Sinclair
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Deschatelets Pascal
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Deschatelets Pascal
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Sullivan Timothy Eugene
Apellis Pharmaceuticals | 4:持股變動聲明-董事 Dunlop A. Sinclair
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Deschatelets Pascal
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Sullivan Timothy Eugene
Apellis Pharmaceuticals | 4:持股變動聲明-董事 Dunlop A. Sinclair
Apellis Pharmaceuticals | 4:持股變動聲明-高管 DeLong Mark Jeffrey
Apellis Pharmaceuticals | 4:持股變動聲明-高管 Chopas James George
暫無數據
暫無數據